BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 24869936)

  • 1. New insights into the spatiotemporal localization of prothrombinase in vivo.
    Ivanciu L; Krishnaswamy S; Camire RM
    Blood; 2014 Sep; 124(11):1705-14. PubMed ID: 24869936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of procoagulant platelets: defining and characterizing the subpopulation binding a functional prothrombinase.
    Fager AM; Wood JP; Bouchard BA; Feng P; Tracy PB
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2400-7. PubMed ID: 21071689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effector cell protease receptor-1, a platelet activation-dependent membrane protein, regulates prothrombinase-catalyzed thrombin generation.
    Bouchard BA; Catcher CS; Thrash BR; Adida C; Tracy PB
    J Biol Chem; 1997 Apr; 272(14):9244-51. PubMed ID: 9083058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of platelet factor Va-dependent thrombin generation by activated protein C at the surface of collagen-adherent platelets.
    Briedé JJ; Tans G; Willems GM; Hemker HC; Lindhout T
    J Biol Chem; 2001 Mar; 276(10):7164-8. PubMed ID: 11113137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated protein C, protein S, and tissue factor pathway inhibitor cooperate to inhibit thrombin activation.
    Li X; Song X; Mahmood DFD; Sim MMS; Bidarian SJ; Wood JP
    Thromb Res; 2023 Oct; 230():84-93. PubMed ID: 37660436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The assembly of the prothrombinase complex on adherent platelets.
    Swords NA; Mann KG
    Arterioscler Thromb; 1993 Nov; 13(11):1602-12. PubMed ID: 8218101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor Xa dimerization competes with prothrombinase complex formation on platelet-like membrane surfaces.
    Koklic T; Chattopadhyay R; Majumder R; Lentz BR
    Biochem J; 2015 Apr; 467(1):37-46. PubMed ID: 25572019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of prothrombinase by human secretory phospholipase A2 involves binding to factor Xa.
    Mounier CM; Hackeng TM; Schaeffer F; Faure G; Bon C; Griffin JH
    J Biol Chem; 1998 Sep; 273(37):23764-72. PubMed ID: 9726985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
    Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ
    Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of fragment 1 of prothrombin with the membrane surface is a prerequisite for optimum expression of factor Va cofactor activity within prothrombinase.
    Bukys MA; Orban T; Kim PY; Nesheim ME; Kalafatis M
    Thromb Haemost; 2008 Mar; 99(3):511-22. PubMed ID: 18327399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va.
    Heeb MJ; Kojima Y; Hackeng TM; Griffin JH
    Protein Sci; 1996 Sep; 5(9):1883-9. PubMed ID: 8880912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa.
    Hackeng TM; van 't Veer C; Meijers JC; Bouma BN
    J Biol Chem; 1994 Aug; 269(33):21051-8. PubMed ID: 8063724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a factor Xa binding site on factor Va near the Arg-506 activated protein C cleavage site.
    Gale AJ; Yegneswaran S; Xu X; Pellequer JL; Griffin JH
    J Biol Chem; 2007 Jul; 282(30):21848-55. PubMed ID: 17553804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Hirudin-like factor Va heavy chain sequences in prothrombinase function.
    Toso R; Camire RM
    J Biol Chem; 2006 Mar; 281(13):8773-9. PubMed ID: 16431918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zymogen-like factor Xa variants restore thrombin generation and effectively bypass the intrinsic pathway in vitro.
    Bunce MW; Toso R; Camire RM
    Blood; 2011 Jan; 117(1):290-8. PubMed ID: 20864578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proposed structural models of the prothrombinase (FXa-FVa) complex.
    Autin L; Steen M; Dahlbäck B; Villoutreix BO
    Proteins; 2006 May; 63(3):440-50. PubMed ID: 16437549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor Va-factor Xa interactions: molecular sites involved in enzyme:cofactor assembly.
    Steen M
    Scand J Clin Lab Invest Suppl; 2002; 237():5-11. PubMed ID: 12570161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylserine-induced factor Xa dimerization and binding to factor Va are competing processes in solution.
    Majumder R; Koklic T; Rezaie AR; Lentz BR
    Biochemistry; 2013 Jan; 52(1):143-51. PubMed ID: 23214401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet factor Xa receptor.
    Tracy PB; Nesheim ME; Mann KG
    Methods Enzymol; 1992; 215():329-60. PubMed ID: 1331708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesicles.
    Larson PJ; Camire RM; Wong D; Fasano NC; Monroe DM; Tracy PB; High KA
    Biochemistry; 1998 Apr; 37(14):5029-38. PubMed ID: 9538022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.